Summary
A program has been initiated to study the distribution of lincosaminides and their biologically active metabolites in the whole animal. Using bioautographic tic analysis, profiles of orally administered clindamycin and its metabolic products in the gastrointestinal tract, liver, blood, kidney and carcass of Sprague-Dawley rats have been constructed. The results of these experiments reveal the significant contribution of the N-demethyl metabolite to observed clindamycin antibacterial activity. From kinetic data it is evident that N-demethylclindamycin persists in the body longer than does clindamycin, further adding to its contribution toin vivo activity.
The sulfoxide metabolites of clindamycin contribute little to the antibacterial activity of this drug. Over the time period studied, clindamycin and its sulfoxide displayed biphasic concentration-time curves, while N-demethylclindamycin and its sulfoxide were continuously increasing in concentration in the gastrointestinal tract indicating reabsorption or return through the biliary system. A material balance revealed that 50% of the administered dose of clindamycin was rapidly metabolized to antibacterially inactive metabolites.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Birkenmeyer, R.D. and Kagan, F. (1970): Lincomycin. XI. Synthesis and Structure of Clindamycin A Potent Antibacterial Agent,J. Med. Chem., 13, 616.
Brodasky, T.F.et al. (1968): The Characterization and Thin-Layer Chromatographic Quantitation of the Human Metabolite of 7-Deoxy-7(S)-Chlorolincomycin (U-21, 251F),J. Antib., 21, 327.
Brodasky, T.F., Lewis, C. and Eble, T.E. (1976): Bioautographic Thin-Layer Chromatographic Analysis of Antibiotics and Their Metabolites in the Whole Animal,J. Chrom., 123, 33.
Parke, D. (1972): Metabolism of Drugs,Chem. in Britain, 8, 102.
Scheline, R. (1973): Metabolism of Foreign Compounds by Gastrointestinal Microorganisms,Pharm. Rev., 25, 451.
Sun, F.F. and Hsi, R.S.P. (1973): Metabolism of Clindamycin I: Absorption and Excretion of Clindamycin in Rat and Dog,J. Pharm. Sci., 62, 1265.
Sun, F.F. (1973): Metabolism of Clindamycin II: Urinary Excretion Products of Clindamycin in Rat and Dog,J. Pharm. Sci., 62, 1657.
Brodasky, T.F. and Lewis, C. (1972): Anin vivo Comparison of the 2- and 3-Phosphate Esters of Clindamycin.,J. Antib., 25, 230.
Brodasky, T.F. and Sun, F.F. (1974): Determination of Clindamycin 2-Palmitate in Clinical Human Serum Samples,J. Pharm. Sci., 63, 360.
Cohen, L.E., McNeill, C.J. and Wells, R.F. (1973): Clindamycin Associated Colitis,JAMA, 223, 1379.
Scott, A.J., Nicholson, G.I. and Kerr, A.R. (1973): Lincomycin as a Cause of Pseudomembranous Colitis,Lancet, 2, 1232.
Tedesco, F.J., Stanley, R.J. and Alpers, D.H. (1974): Diagnostic Features of Clindamycin Associated Pseudomembranous Colitis,New Eng. J. Med., 290, 841.
Alpers, D. and Grimme, N. (1976): Clindamycin Hydrochloride Inhibits DNA Synthesis in Mammalian Colonic Mucosa,Gastroenterology, 70, 859.
Devroede, G., Poissoh, J., Madarnas, P., Beaudry, R., Stroem, B. and Haddad, H. (1976): Lincomycin-Clindamycin Colitis is Not an Entity,Gastroenterology, 70, 877.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brodasky, T.F., Lewis, C. & Eble, T.E. Distribution and metabolism of antibiotics in the whole animal I. Clindamycin in the rat. European Journal of Drug Metabolism and Pharmacokinetics 2, 149–156 (1977). https://doi.org/10.1007/BF03189299
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189299